Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-Play: mFOLFIRINOX in Stage IV Colorectal Cancer
NCT05354817Phase 2Unknown
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, folinic acid, irinotecan, fluorouracil in colorectal cancer (CRC), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.
02
Drugs
oxaliplatinfolinic acidirinotecanfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05354817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05354817.